Table 2.
BM Chimera EAE Clinical Disease Characteristics
| Donor listed first, recipient second | Average day disease onset | Average maximum disease score | Sum daily average disease score | Disease index | Percent mortality |
|---|---|---|---|---|---|
| WT→WT | 13.92 | 2.73††† | 105.2 | 755.6††† | 7.00 |
| CD44-KO→WT | 12.88 | 4.09∗∗†† | 163.9 | 1273.3∗∗†† | 18.75 |
| WT→CD44-KO | 13.67 | 3.80∗† | 151.2 | 1106.7∗†† | 31.25 |
| CD44-KO→CD44-KO | 12.06 | 4.75∗∗∗ | 212.2 | 1758.69∗∗∗ | 68.75 |
EAE disease measurements from BM chimeric mice.
∗P < 0.05, ∗∗P < 0.005, and ∗∗∗P < 0.0001 versus WT→WT.
†P < 0.006, ††P < 0.0004, and †††P < 0.0001 versus KO→KO.